✦ LIBER ✦

Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines

✍ Scribed by K. Yamazaki; Hiroshi Isobe; Tarou Hanada; Tomoko Betsuyaku; Atsushi Hasegawa; Nobuyuki Hizawa; Shigeaki Ogura; Yoshikazu Kawakami

Publisher: Springer
Year: 1996
Tongue: English
Weight: 332 KB
Volume: 39
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050559

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of dna cleavage induced by et

Comparison of dna cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase ii inhibitors

✍ Monica Binaschi; Giovanni Capranico; Paola De Isabella; Mariangela Mariani; Rosa 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 653 KB

Amplification of the topoisomerase ii α

Amplification of the topoisomerase ii α gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue

✍ W. Nicol Keith; Robert Brown; K. B. Tan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

n sylvan la (K. B.T.) DNA was prepared from normal tissue and I9 lung cancer cell lines. Using probes which detect restriction fragment length polymorphisms at both the topoisomerase II u and p loci, heterozygosity was detected at a frequency of 0. I 7 and 0.37 for the

Relationship of mRNA expressions of RanB

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines

✍ Yoshitsugu Horio; Hirotaka Osada; Junichi Shimizu; Shizu Ogawa; Toyoaki Hida; Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 424 KB

Accumulation of anthracenyl-amino acid t

Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography

✍ Jeffrey Cummings; Ian Meikle; Janet S. Macpherson; John F. Smyth 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 727 KB

Effects of wild-type p53 expression on t

Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines

✍ Daniel Hochhauser; Nikola I. Valkov; Jana L. Gump; Irene Wei; Carolyn O'Hare; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

The p53 null HL-60 cell line was transfected with plasmids coding for either the wild-type p53 or mutant p53 gene. The stable expression of wild-type p53 resulted in a significant increase in sensitivity to the topoisomerase II poisons etoposide and doxorubicin, but not to the topoisomerase II inhib

A truncated cytoplasmic topoisomerase II

A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34

✍ Shelagh E.L. Mirski; Kathryn E. Sparks; Qiang Yu; Alexander J. Lang; Nidhi Jain; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB

To study the problem of acquired resistance to widely used anti-cancer drugs that target the 170 kDa topoisomerase IIalpha (topo IIalpha), a drug-resistant human small-cell lung cancer cell line, H209/VP, was selected in VP-16. H209/VP cells express reduced levels of the 170 kDa topo IIalpha that is